CN Patent

CN109705057B — 组蛋白去乙酰化酶抑制剂及其制备方法与用途

Assigned to Hitgen Inc · Expires 2023-05-30 · 3y expired

What this patent protects

本发明公开了一种组蛋白去乙酰化酶抑制剂及其制备方法与用途，本发明公开了式Ⅰ所示的化合物、或其晶型、或其药学上可接受的盐、或其溶剂合物、或其前体药物、或其代谢产物。本发明公开的式Ⅰ所示的新化合物，表现出了良好的去乙酰化酶抑制活性，为临床治疗与组蛋白去乙酰化酶活性异常相关的疾病提供了一种新的药用可能。

USPTO Abstract

本发明公开了一种组蛋白去乙酰化酶抑制剂及其制备方法与用途，本发明公开了式Ⅰ所示的化合物、或其晶型、或其药学上可接受的盐、或其溶剂合物、或其前体药物、或其代谢产物。本发明公开的式Ⅰ所示的新化合物，表现出了良好的去乙酰化酶抑制活性，为临床治疗与组蛋白去乙酰化酶活性异常相关的疾病提供了一种新的药用可能。

Drugs covered by this patent

Patent Metadata

Patent number
CN109705057B
Jurisdiction
CN
Classification
—
Expires
2023-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Hitgen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.